The effect of ΔG on the transport and oral absorption of macromolecules

被引:31
作者
Salama, NN
Fasano, A
Thakar, M
Eddington, ND
机构
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Pharmacokinet Biopharmaceut Lab, Baltimore, MD 21201 USA
[2] Univ Maryland, Div Pediat Gastroenterol & Nutr, Baltimore, MD 21201 USA
[3] Univ Maryland, Gastroenterol Sect, Ctr Vaccine Dev, Dept Physiol,Sch Med, Baltimore, MD 21201 USA
关键词
Delta G; Zot; bioavailability; absorption enhancer; oral absorption;
D O I
10.1002/jps.20052
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Delta G (DeltaG) is the biologically active fragment of Zonula Occludens Toxin (Zot), an absorption enhancer, that reversibly opens the tight junctions of epithelial and endothelial cells in the small intestine and brain. This study evaluates the possible use of DeltaG in enhancing the oral bioavailability of macromolecules using large paracellular markers as model agents. The transport of [C-14]Inulin and [C-14] PEG4000 was evaluated across Caco-2 cells with DeltaG (0, 100, 180 mug/ml). The apparent permeability coefficients (P-app) were calculated. The in vitro toxicity of DeltaG (180 mug/ml) was assessed. Sprague Dawley rats were dosed intraduodenally (ID) with the following treatments: [C-14]Inulin or [C-14] PEG4000 (30 muci/kg) w/o DeltaG (720 mug/kg)/protease inhibitors (PI). Blood was collected and plasma was analyzed for radioactivity. DeltaG (180 mug/ml) increased [C-14]Inulin and [C-14] PEG4000 P-app by 82.6 and 24.4%, respectively, without any toxicity. After ID administration with DeltaG/PI, C-max and AUC were significantly (p < 0.05) increased for both Inulin and PEG4000. However, Inulin displayed greater enhancement ratios in vitro and in vivo. This study suggests that DeltaG may be used to enhance the oral bioavailability of macromolecules (e.g., proteins) after coadministration through modulation of paracellular transport. (C) 2004 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:1310 / 1319
页数:10
相关论文
共 44 条
[1]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .7. EFFECTS OF PHARMACEUTICAL SURFACTANT EXCIPIENTS AND BILE-ACIDS ON TRANSEPITHELIAL PERMEABILITY IN MONOLAYERS OF HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ANDERBERG, EK ;
NYSTROM, C ;
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (09) :879-887
[2]   Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond [J].
Artursson, P ;
Borchardt, RT .
PHARMACEUTICAL RESEARCH, 1997, 14 (12) :1655-1658
[3]   THE USE OF CULTURED EPITHELIAL AND ENDOTHELIAL-CELLS FOR DRUG TRANSPORT AND METABOLISM STUDIES [J].
AUDUS, KL ;
BARTEL, RL ;
HIDALGO, IJ ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1990, 7 (05) :435-451
[4]  
Aungst BJ, 2000, J PHARM SCI, V89, P429, DOI 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO
[5]  
2-J
[6]   THE APPLICATION OF CELL-CULTURE SYSTEMS IN DRUG DISCOVERY AND DEVELOPMENT [J].
BORCHARDT, R .
JOURNAL OF DRUG TARGETING, 1995, 3 (03) :179-182
[7]  
BRAYDEN DJ, 1997, PHARM NEWS, V4, P11
[8]   PROTEIN-KINASE INHIBITORS PREVENT JUNCTION DISSOCIATION INDUCED BY LOW EXTRACELLULAR CALCIUM IN MDCK EPITHELIAL-CELLS [J].
CITI, S .
JOURNAL OF CELL BIOLOGY, 1992, 117 (01) :169-178
[9]   Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin [J].
Cox, DS ;
Raje, S ;
Gao, HL ;
Salama, NN ;
Eddington, ND .
PHARMACEUTICAL RESEARCH, 2002, 19 (11) :1680-1688
[10]   Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin [J].
Cox, DS ;
Gao, HL ;
Raje, S ;
Scott, KR ;
Eddington, ND .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2001, 52 (02) :145-150